A Proposed Roadmap for Parkinson's Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein.
Merchant KM, Cedarbaum JM, Brundin P, Dave KD, Eberling J, Espay AJ, Hutten SJ, Javidnia M, Luthman J, Maetzler W, Menalled L, Reimer AN, Stoessl AJ, Weiner DM; The Michael J. Fox Foundation Alpha Synuclein Clinical Path Working Group.
Merchant KM, et al. Among authors: menalled l.
J Parkinsons Dis. 2019;9(1):31-61. doi: 10.3233/JPD-181471.
J Parkinsons Dis. 2019.
PMID: 30400107
Free PMC article.